Week in review: Gene therapy for LCA, Susvimo voluntary recall, smoking accelerates RNFL thinning
- Posted on: Oct 21 2022
- Leave a response
An experimental gene therapy shows promise in Leber congenital amaurosis (LCA), Genentech issues a voluntary recall for Susvimo, and heavy smoking leads to increased RNFL thinning.
Source: AAO
Posted in: Uncategorized
